Preview this article:
Zoom in

Emergence of telithromycin resistance in in Japan, Page 1 of 1

| /docserver/preview/fulltext/jmm/56/12/1705-1.gif

There is no abstract available for this article.
Use the preview function to the left.


Article metrics loading...

Loading full text...

Full text loading...



  1. Bogdanovich T., Bozdogan B., Appelbaum P. C. 2006; Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae . Antimicrob Agents Chemother 50:893–898 [CrossRef]
    [Google Scholar]
  2. Bozdogan B., Appelbaum P. C. 2004; Macrolide resistance in streptococci and Haemophilus influenzae . Clin Lab Med 24:455–475 [CrossRef]
    [Google Scholar]
  3. CLSI 2006 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically , approved standard M7–A7 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  4. Hansen L. H., Mauvais P., Douthwaite S. 1999; The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA. Mol Microbiol 31:623–631 [CrossRef]
    [Google Scholar]
  5. Peric M., Bozdogan B., Jacobs M. R., Appelbaum P. C. 2003; Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother 47:1017–1022 [CrossRef]
    [Google Scholar]
  6. Peric M., Bozdogan B., Galderisi C., Krissinger D., Rager T., Appelbaum P. C. 2004; Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S. J Antimicrob Chemother 54:393–400 [CrossRef]
    [Google Scholar]

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error